A Manitoba woman is suing St. Boniface Hospital and two staff after undergoing a medical procedure that she says left her ...

Pacira BioSciences PCRX announced that the FDA has cleared its application to market a new Smart Tip for the iovera system ...

Scientists Discover New Receptor for Nerve Growth Factor--a Promising Target for Treating Pain Dec. 5, 2024 — Researchers have found a new receptor for nerve growth factor that plays an ...

Physical therapy can be effective in treating a condition more than 3 million Americans live with every day: chronic pain.

Nalu Medical, Inc. (“Nalu”), a leader in peripheral nerve stimulation, announced the publication of a study in Pain Management journal showing that the use of Nalu PNS therapy in chronic pain patients ...

Pacira launches a new iovera° Smart Tip for chronic back pain relief, offering an alternative to radiofrequency ablation with ...

Polyneuropathy Treatment Market Benefiting from Innovations in Neuromodulation Techniques and High Focus on Pain ManagementRockville, MD , Jan. 07, 2025 (GLOBE NEWSWIRE) -- According to Fact.MR, a ...

Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of ...

For people suffering from chronic knee pain, especially those over 50, a new treatment is offering hope and relief.

A single-center retrospective study in China found a significant association between pain duration and intensity in patients ...

Treatment with XG005 resulted in statistically significant and clinically meaningful reduction in post-surgical pain ...

BHV-2100 is under clinical development by Biohaven and currently in Phase II for Neuropathic Pain (Neuralgia).